Market Cap 64.18M
Revenue (ttm) 90,000.00
Net Income (ttm) -68.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -76,322.22%
Debt to Equity Ratio -9.68
Volume 3,548,000
Avg Vol 6,470,626
Day's Range N/A - N/A
Shares Out 137.04M
Stochastic %K 80%
Beta 1.64
Analysts Strong Sell
Price Target $5.24

Company Profile

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term r...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 902 8800
Website: fractyl.com
Address:
3 Van de Graaff Drive, Suite 200, Burlington, United States
Meowzilla1
Meowzilla1 Feb. 24 at 1:08 AM
;@SqueezeSharkie is operating on a whole different level, easily ahead of 90% of the traders on this platform. If you’re not paying attention yet, you’re missing out. Go give him a follow. It’s completely free and only takes a second 💎 $SLN $CGON $GUTS $VRE 2
0 · Reply
BioRich
BioRich Feb. 24 at 12:23 AM
$GUTS I continue to scour and challenge $GUTS for weaknesses and blind spots, and I keep finding conviction and excitement. I've lowered my SP average to $0.6645 and have ADDED EVERY DAY since the overreaction SP drop.
2 · Reply
BioRich
BioRich Feb. 24 at 12:22 AM
$GUTS remains on target to hit massive milestones, with the next one (announcing randomization of 300+ subjects in the REMAIN-1 Pivotal Cohort Study...the one that will be used to apply for approval from the FDA) coming very so This catalyst will also serve as an opportunity for our great CEO to highlight why recent SP response was misinformed and an dramatic overreaction by folks that either 1) Don't understand the concept of "Pilot" vs. "Pivotal" studies, or 2) An opportunity for WS to destroy SP to load up cheap shares knowing we're sitting on a blockbuster. Congrats to those have remained, and welcome to those who have recently joined. Cheers! $XBI
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor Feb. 23 at 6:56 PM
$GUTS what’s the catalyst here?
2 · Reply
BioRich
BioRich Feb. 23 at 2:53 PM
$ALUR FDA APPROVAL!!!! We got another one. This is great news for alternate therapies like $GUTS (Fractyl Health). Congrats to those that believed in $ALUR's Gastric Balloon and cheers to those that still believe in $GUTS's Revita and Rejuva. Exciting times on the horizon. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
1 · Reply
Geraldgenofranco1953
Geraldgenofranco1953 Feb. 23 at 2:26 PM
$SLS $ALT $ABOS $GUTS Let us go Jack!
0 · Reply
jacksparo
jacksparo Feb. 23 at 1:26 PM
$SLS $ALT $ABOS $GUTS I will be watching and sharing my live updates in my Telegram Biotech group let us see what this week will bring!
1 · Reply
BioRich
BioRich Feb. 23 at 4:05 AM
$VNDA another de-risking move for the company. When do we start to see new BO offers come in? Exciting times for this company. They've been very catalyst rich and have hit some major homeruns. Not suggesting to transfer out of $VNDA (I'm not selling any shares), but if you're looking for another catalyst rich opportunity that has multiple X potential, take a look at $GUTS. Took a big hit recently on pilot trial data (which was treated by misunderstood folks as pivotal trial data). The company continues to plow along and the next catalyst can come as soon as tomorrow. This will be critical because the CEO has an opportunity to strengthen confidence following recent SP drop. Exciting times in Bio. Cheers to the Vanda Family. This was a big win!
0 · Reply
GeneMachine
GeneMachine Feb. 21 at 4:44 PM
$GUTS https://youtu.be/X-N1ZmdZT44?si=x7pCRwK9sizyC_cX
0 · Reply
Catmando3
Catmando3 Feb. 21 at 3:30 AM
$GUTS why didn’t i buy more at .40. I have 30k shares at .48
1 · Reply
Latest News on GUTS
Fractyl Health, Inc. (GUTS) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 8:21 PM EST - 3 months ago

Fractyl Health, Inc. (GUTS) Q3 2025 Earnings Call Transcript


Fractyl Health, Inc. - Special Call

Sep 26, 2025, 11:07 AM EDT - 5 months ago

Fractyl Health, Inc. - Special Call


Fractyl Health, Inc. (GUTS) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 8:00 PM EDT - 6 months ago

Fractyl Health, Inc. (GUTS) Q2 2025 Earnings Call Transcript


Fractyl Health Announces Proposed Public Offering

Aug 5, 2025, 4:15 PM EDT - 7 months ago

Fractyl Health Announces Proposed Public Offering


Fractyl Health: Speculative Buy With Binary Risk

Jul 16, 2025, 10:13 AM EDT - 7 months ago

Fractyl Health: Speculative Buy With Binary Risk


Fractyl Health, Inc. (GUTS) Q1 2025 Earnings Call Transcript

May 13, 2025, 8:43 PM EDT - 10 months ago

Fractyl Health, Inc. (GUTS) Q1 2025 Earnings Call Transcript


Fractyl Health, Inc. (GUTS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 8:01 PM EST - 1 year ago

Fractyl Health, Inc. (GUTS) Q4 2024 Earnings Call Transcript


Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:01 PM EST - 1 year ago

Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript


Meowzilla1
Meowzilla1 Feb. 24 at 1:08 AM
;@SqueezeSharkie is operating on a whole different level, easily ahead of 90% of the traders on this platform. If you’re not paying attention yet, you’re missing out. Go give him a follow. It’s completely free and only takes a second 💎 $SLN $CGON $GUTS $VRE 2
0 · Reply
BioRich
BioRich Feb. 24 at 12:23 AM
$GUTS I continue to scour and challenge $GUTS for weaknesses and blind spots, and I keep finding conviction and excitement. I've lowered my SP average to $0.6645 and have ADDED EVERY DAY since the overreaction SP drop.
2 · Reply
BioRich
BioRich Feb. 24 at 12:22 AM
$GUTS remains on target to hit massive milestones, with the next one (announcing randomization of 300+ subjects in the REMAIN-1 Pivotal Cohort Study...the one that will be used to apply for approval from the FDA) coming very so This catalyst will also serve as an opportunity for our great CEO to highlight why recent SP response was misinformed and an dramatic overreaction by folks that either 1) Don't understand the concept of "Pilot" vs. "Pivotal" studies, or 2) An opportunity for WS to destroy SP to load up cheap shares knowing we're sitting on a blockbuster. Congrats to those have remained, and welcome to those who have recently joined. Cheers! $XBI
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor Feb. 23 at 6:56 PM
$GUTS what’s the catalyst here?
2 · Reply
BioRich
BioRich Feb. 23 at 2:53 PM
$ALUR FDA APPROVAL!!!! We got another one. This is great news for alternate therapies like $GUTS (Fractyl Health). Congrats to those that believed in $ALUR's Gastric Balloon and cheers to those that still believe in $GUTS's Revita and Rejuva. Exciting times on the horizon. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
1 · Reply
Geraldgenofranco1953
Geraldgenofranco1953 Feb. 23 at 2:26 PM
$SLS $ALT $ABOS $GUTS Let us go Jack!
0 · Reply
jacksparo
jacksparo Feb. 23 at 1:26 PM
$SLS $ALT $ABOS $GUTS I will be watching and sharing my live updates in my Telegram Biotech group let us see what this week will bring!
1 · Reply
BioRich
BioRich Feb. 23 at 4:05 AM
$VNDA another de-risking move for the company. When do we start to see new BO offers come in? Exciting times for this company. They've been very catalyst rich and have hit some major homeruns. Not suggesting to transfer out of $VNDA (I'm not selling any shares), but if you're looking for another catalyst rich opportunity that has multiple X potential, take a look at $GUTS. Took a big hit recently on pilot trial data (which was treated by misunderstood folks as pivotal trial data). The company continues to plow along and the next catalyst can come as soon as tomorrow. This will be critical because the CEO has an opportunity to strengthen confidence following recent SP drop. Exciting times in Bio. Cheers to the Vanda Family. This was a big win!
0 · Reply
GeneMachine
GeneMachine Feb. 21 at 4:44 PM
$GUTS https://youtu.be/X-N1ZmdZT44?si=x7pCRwK9sizyC_cX
0 · Reply
Catmando3
Catmando3 Feb. 21 at 3:30 AM
$GUTS why didn’t i buy more at .40. I have 30k shares at .48
1 · Reply
CocoPeechu
CocoPeechu Feb. 21 at 2:47 AM
$GUTS An end-of-randomization PR is likely coming next week. This isn’t about hyping a sudden run-up, but it would be the first time management speaks since the results — an important milestone in itself. For those who believe in the science and see the long-term thesis continuing to take shape, this moment matters. Progress is being made, confidence is quietly rebuilding, and better times may be ahead.
0 · Reply
GeneMachine
GeneMachine Feb. 21 at 2:01 AM
$GUTS https://youtu.be/r-GKHKKosu0?si=e3uZt4Di6tOncpHT
0 · Reply
BioRich
BioRich Feb. 21 at 1:04 AM
$GUTS Since Stocktwits was lagging, here's how we closed the week. Feeling pretty damn good if you ask me. Generational wealth potential for those that believe. #FractylForward $XBI
1 · Reply
BioRich
BioRich Feb. 20 at 11:17 PM
$VNDA Hell yeah! Congrats to those that still believed! Next big winner after being beaten down is $GUTS LFG!!!
2 · Reply
GeneMachine
GeneMachine Feb. 20 at 9:29 PM
$GUTS https://youtu.be/-urmcz2RSwI?si=Nb6HjCotnXCvqFhj
0 · Reply
BioRich
BioRich Feb. 20 at 8:03 PM
$GUTS Patience and conviction often get rewarded. We're seeing that already and believe we'll see it numerous times in the coming days, weeks, months. #FractylForward
0 · Reply
SankaYield
SankaYield Feb. 20 at 2:20 PM
0 · Reply
dumberdore
dumberdore Feb. 20 at 12:12 AM
$GUTS Eric Topol shared this article on Linkedin about 3 weeks ago: https://www.washingtonpost.com/health/2026/01/24/fractyl-glp1-gene-therapy/
1 · Reply
SankaYield
SankaYield Feb. 19 at 10:09 PM
$GUTS who is buying, don't institutional firms buy at end of day?
1 · Reply
Megabyte48
Megabyte48 Feb. 19 at 9:16 PM
$GUTS hope they stack news, they did all the 13Fs, now a insider buy update be great, then the february randomization update, and then earnings.
0 · Reply
Megabyte48
Megabyte48 Feb. 19 at 9:09 PM
$GUTS somebody's butt hurts today, .02 yesterday, .04 today, .08 tomorrow or more??
1 · Reply
Aawilliam2003
Aawilliam2003 Feb. 19 at 8:56 PM
$GUTS some dumbass is buying. Or this is a fake pump to drop an offering. The company itself is a complete basket case
2 · Reply